MamaConecta: Digital Tool for Maternal Mental Health

Launched by A THOUSAND COLIBRIS, S.L · May 28, 2024

Keywords

ClinConnect Summary

The MamaConecta trial is studying a digital health tool called the Dana app, designed to help improve the mental well-being of women during pregnancy and after giving birth. The trial aims to see if using the app can enhance overall happiness, help detect mental health issues earlier, support healthcare professionals in diagnosing these problems, and even improve the health and development of infants. Participants will use the app from 12-14 weeks of pregnancy until their baby is 24 months old, and they will regularly check in on their emotional health and lifestyle, as well as their baby's development.

To join this study, women should be between 12-14 weeks pregnant, have had their first ultrasound, and be able to read and understand Spanish. They also need to have access to a smartphone with the internet and be comfortable using apps. Throughout the trial, participants will receive support and monitoring to help ensure their mental health and that of their baby are on track. This research is taking place at several hospitals in Spain, and it aims to improve healthcare for new mothers and their children.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Gestational age between 12-14 weeks of gestation.
• • The first obstetric ultrasound has been performed.
• • Women who know how to read and understand Spanish.
• • Women who have access to a mobile phone with an internet connection (data or wifi)
• • Women who have knowledge of technology tools via app.
• • Have signed the informed consent to participate in the study.
• Exclusion Criteria:
• • Termination of pregnancy, or early miscarriage
• • Perinatal loss at any time during pregnancy.
• • Severe mental pathology or moderate unstable mental pathology.
• • Consumption of toxic substances.